Plymouth Meeting dental support organization makes major acquisition in Texas
Mid-Atlantic Dental Partners, a dental support organization based in Plymouth Meeting, continued its national expansion with the acquisition of a Texas firm. Terms of the deal for DentalOne Partners from Dental Investments were not disclosed. Under the acquisition, Mid-Atlantic Dental Partners purchased the equity of DentalOne’s operating subsidiaries in an all-cash deal. Dental support organizations, or DSOs, provide business management and other non-clinical support services to dental practices… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 21, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Batch of CCG mergers approved for next year
NHS England has approved a first tranche of clinical commissioning group mergers for April 2020, but has declined to say which ones. (Source: HSJ)
Source: HSJ - October 18, 2019 Category: UK Health Source Type: news

Triangle pharma execs link up to launch new company
Just months after selling off their last comapny in an acquisition, a pair of Triangle executives are already launching a new contract manufacturing outfit – one with an expensive price tag and ambitious expansion goals. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 17, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

PatientsLikeMe founder Jamie Heywood: patient engagement is vital to drive change in care
Heywood spoke at the Society of Participatory Medicine's annual conference about the importance of patient involvement, and how the company is continuing its work following this summer's acquisition by UnitedHealth Group.   (Source: mobihealthnews)
Source: mobihealthnews - October 16, 2019 Category: Information Technology Source Type: news

Eyevance Pharmaceuticals Acquires TOBRADEX(R) ST and NATACYN(R)
Acquisition bolsters Eyevance's position as an emerging leader in treating anterior segment and ocular surface conditions Company executes its 7th strategic transaction in two years FORT WORTH, Texas, Oct. 16, 2019 -- (Healthcare Sales & Marketing Ne... Biopharmaceuticals, Ophthalmology, Acquisitions Eyevance Pharmaceuticals, TOBRADEX, tobramycin, NATACYN, natamycin, Novartis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2019 Category: Pharmaceuticals Source Type: news

J & amp;J Talks Up Surgical Robotics Plans
Few medtech sectors are as hot as surgical robotics is right now, so it comes as no surprise that analysts tried to dig for information about Johnson & Johnson's plans for the market during the company's third-quarter earnings call Tuesday. "I couldn't be more bullish around how J&J is going to create value in this space," Ashley McEvoy, EVP and worldwide chairman of Johnson & Johnson's medical device segment, said during the call in response to an analyst's question about surgical robotics. "The goal that we're trying to achieve is really to make medical interventions smarter, less invasive, mor...
Source: MDDI - October 15, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

FY20 Appropriations Bills: National Oceanic and Atmospheric Administration
The House and Senate have advanced spending bills that would reject the administration ’s proposed cuts to the National Oceanic and Atmospheric Administration’s weather and climate research programs for fiscal year 2020, while ramping down funding for satellite acquisition. (Source: FYI: The AIP Bulletin of Science Policy News)
Source: FYI: The AIP Bulletin of Science Policy News - October 15, 2019 Category: Physics Authors: aschwarber Source Type: news

Mindful parenting is associated with adolescents' difficulties in emotion regulation through adolescents' psychological inflexibility and self-compassion - Moreira H, Cristina Canavarro M.
The acquisition and mastery of emotion regulation is one of the most important developmental tasks of adolescence. Difficulties in regulating emotions are one of the most robust risk factors for the development of difficulties and psychopathology. This stu... (Source: SafetyLit)
Source: SafetyLit - October 14, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Md. tech exits: Here's who went public, got acquired or did some acquiring so far this year
The Maryland tech scene has seen two multimillion-dollar public exits this year, and even a billion-dollar acquisition deal. These deals can mean more money, jobs and opportunities coming into the state and bolstering a tech ecosystem that is growing stronger by the year. A pair of biotechnology companies launched initial public offerings this year, raising nearly $260 million in public funds between them. Gaithersburg -based Viela Bio's IPO was most recent and most impactful. The clinical-stage… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 14, 2019 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

WLR Petsmart Project Attracts $4.2M Acquisition (Real Deals)
An investment group composed of companies led by Haitham Alley and Bradley Davis purchased the Petsmart-Banfield Pet Hospital at 11400 Financial Centre Parkway. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - October 14, 2019 Category: American Health Source Type: news

10 digital health mergers and acquisitions from Q3 2019
The deals include big names like Philips, long-time startup players like Mango Health  and a dose of private equity. (Source: mobihealthnews)
Source: mobihealthnews - October 10, 2019 Category: Information Technology Source Type: news

Orlando staffing firm to expand after health care acquisition
A local staffing firm is positioning itself to expand after acquiring a Florida health care staffing company. Orlando-based Loyal Source Government Services LLC on Sept. 9 closed on the purchase of Palm Harbor-based SonoTemps Inc. Terms of the deal were not disclosed. The deal expands Loyal Source's health care services. In addition, the firm is expected to hire more workers, with at least 10 Orlando job s to start, Steve Lockwood, president of travel nursing at Loyal Source, told Orlando Business… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 10, 2019 Category: Biotechnology Authors: Ryan Lynch Source Type: news

Prevalence and correlates of partner violence among adolescent girls and young women: evidence from baseline data of a cluster randomised trial in Tanzania - Nyato D, Materu J, Kuringe E, Zoungrana J, Mjungu D, Lemwayi R, Majani E, Mtenga B, Nnko S, Munisi G, Shao A, Wambura M, Changalucha J, Drake M, Komba A.
BACKGROUND: Little has been documented about partner violence among adolescent girls and young women (AGYW) who are out of school, a factor associated with HIV acquisition. To understand areas for prioritising HIV prevention intervention efforts, we explor... (Source: SafetyLit)
Source: SafetyLit - October 10, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Integer Holdings Corp. acquires assets from Pennsylvania manufacturer
Integer Holdings Corp. (NYSE: ITGR), a medical device outsource manufacturer headquartered in Plano, announced Monday that it has acquired assets from US BioDesign.   Founded in 2011, the Quakertown, Pennsylvania company is a manufacturer of braided and woven biomedical structures for disposable and implantable medical devices in the cardiovascular, neurovascular and general surgery markets.  With this acquisition, Integer's portfolio has grown within the $ 1.2 billion industry. As of today, Integer… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 7, 2019 Category: Pharmaceuticals Authors: David Ajamy Source Type: news

Integer Holdings Corp. acquires assets from Pennsylvania manufacturer
Integer Holdings Corp. (NYSE: ITGR), a medical device outsource manufacturer headquartered in Plano, announced Monday that it has acquired assets from US BioDesign.   Founded in 2011, the Quakertown, Pennsylvania company is a manufacturer of braided and woven biomedical structures for disposable and implantable medical devices in the cardiovascular, neurovascular and general surgery markets.  With this acquisition, Integer's portfolio has grown within the $ 1.2 billion industry. As of today, Integer… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 7, 2019 Category: Biotechnology Authors: David Ajamy Source Type: news

Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
The new fund has already received a commitment from an anchor investor, Vincent Tchenguiz Recent exits of Accelmed's ventures portfolio companies include the acquisition of Eximo Medical by AngioDynamics for $66 million and Endospan, that entered into a... Devices, Venture Capital Accelmed (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2019 Category: Pharmaceuticals Source Type: news

Financially-challenged CCG appoints new chief ahead of merger
Shropshire, and Telford and Wrekin clinical commissioning groups have appointed a joint accountable officer ahead of their upcoming merger in 2020. (Source: HSJ)
Source: HSJ - October 7, 2019 Category: UK Health Source Type: news

Investors ’ Faith in Endotronix Continues with Expanded D Round
Sometimes medtech companies need more than a nod from FDA for a product to be successful. And sometimes - if it isn’t in place already – companies need to look at a viable reimbursement path before they can even think of filing for approval. That’s the strategy Endotronix is employing concerning the clinical development of the Cordella Pulmonary Artery Sensor (Cordella Sensor). The Lisle, Il-based company is jointly pursuing FDA approval of the technology and reimbursement from the Centers for Medicare & Medicaid Services. To run a robust clinical trial to support b...
Source: MDDI - October 3, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

AngioDynamics Has Laser Focus on PAD with New Acquisition
The M&A’s just keep coming this week as AngioDynamics announced a plan acquire Eximo Medical. Latham, NY-based AngioDynamics will pick up the company for about $46 million in up-front consideration with the possibility of up to $20 million in milestones. The announcement comes a day after Lantheus Holdings revealed its intention to acquire Progenics Pharmaceuticals. Eximo has developed technology that delivers short, high-powered pulsed-laser energy in 355nm wavelength without compromising the integrity of its fiber optic cables during atherectomy procedures. The technology addresses the risk of perfo...
Source: MDDI - October 3, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Lantheus Takes a Dive into Pharma with Proposed Acquisition
Lantheus Holdings is expanding its presence in the world of radiopharmaceutical diagnostics through a newly-proposed acquisition. On Wednesday, the North Billerica, MA-based company announced it would acquire Progenics Pharmaceuticals, an oncology company developing solutions to find, fight, and follow cancer in an all-stock transaction. The transaction has been unanimously approved by the Boards of Directors of both companies. Under the terms of the agreement, Lantheus Holdings will acquire all of the issued and outstanding common shares of Progenics stock at a fixed exchange ratio. Progenics shareholders will receive 0.2...
Source: MDDI - October 3, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Imaging Source Type: news

Nebraska company buys Casa Grande provider of in-home adult care services
Mosaic has acquired At Home Solutions, an in-home service provider based in Casa Grande. Mosaic, an Omaha, Nebraska-based national nonprofit that helps aging adults and people with disabilities, provides various services to its 4,500 clients across 11 states. Mosaic is affiliated with Soreo In-Home Supports, a service that helps people remain as independent as possible and stay in the ir homes. At Home Solutions has been incorporated into Mosaic's Soreo branch of services as part of the acquisition… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 3, 2019 Category: Pharmaceuticals Authors: Serena O'Sullivan Source Type: news

Shield Healthcare acquires two entities for undisclosed sum
Following the acquisitions, Shield Healthcare aims to increase its presence in gynaecology and paediatrics, a company release said here on Thursday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2019 Category: Pharmaceuticals Source Type: news

Malvern gene therapy company completes reverse merger
Chester County gene therapy and biopharmaceutical company Ocugen has completed its previously announced reverse merger with Histogenics Corp., a publicly traded company based in Boston. Ocugen, which is developing new treatments for rare and underserved eye diseases, is now trading — at $2.50 per share Tuesday afternoon — on the Nasdaq Capital Market under the ticker symbol “OCGN.”  The executive team at Ocugen, led by Chairman and CEO Shankar Musunuri, is running the c ombined company… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 1, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Malvern gene therapy company completes reverse merger
Chester County gene therapy and biopharmaceutical company Ocugen has completed its previously announced reverse merger with Histogenics Corp., a publicly traded company based in Boston. Ocugen, which is developing new treatments for rare and underserved eye diseases, is now trading — at $2.50 per share Tuesday afternoon — on the Nasdaq Capital Market under the ticker symbol “OCGN.”  The executive team at Ocugen, led by Chairman and CEO Shankar Musunuri, is running the c ombined company… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 1, 2019 Category: Biotechnology Authors: John George Source Type: news

Humana names new top executive
Louisville-based Humana Inc. has named Jennifer Bazante to the position of chief marketing officer, a newly created role for the company. Bazante will develop strategies for member acquisition and engagement, enhance Humana’s brand equity and continue Humana's reputation as an innovative organization. She will also oversee Humana’s strategy for both direct-to-consumer and business-to-business marketing, according to a news rele ase from the company. She joined Humana (NYSE: HUM) in 2014 as… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 1, 2019 Category: Biotechnology Authors: Chris Larson Source Type: news

Humana names new top executive
Louisville-based Humana Inc. has named Jennifer Bazante to the position of chief marketing officer, a newly created role for the company. Bazante will develop strategies for member acquisition and engagement, enhance Humana’s brand equity and continue Humana's reputation as an innovative organization. She will also oversee Humana’s strategy for both direct-to-consumer and business-to-business marketing, according to a news rele ase from the company. She joined Humana (NYSE: HUM) in 2014 as… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 1, 2019 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

Sobi to Acquire Dova Pharmaceuticals Creating a Global Growth Platform in Haematology
The acquisition of Dova provides Sobi with Doptelet (avatrombopag), a differentiated on-market product in Chronic Immune Thrombocytopenia (ITP), a well established and growing market, for Chronic Liver Disease (CLD) and an ongoing phase 3 trial in Chemothe... Biopharmaceuticals, Mergers & Acquisitions Swedish Orphan Biovitrum, Sobi , Dova Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 30, 2019 Category: Pharmaceuticals Source Type: news

The capacity for acute exercise to modulate emotional memories: a review of findings and mechanisms - Keyan D, Bryant RA.
Anxiety disorders, such as posttraumatic stress disorder, are underpinned by fear learning mechanisms. This review outlines how acute bouts of exercise can moderate fear memory acquisition, consolidation, and extinction. These fear memory mechanisms are ce... (Source: SafetyLit)
Source: SafetyLit - September 30, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Rite Aid ’s Turnaround Hinges On Health Plans, Not Amazon
Rite Aid ’s relationships with health insurance plans are a priority to turning around the drugstore chain rather than another attempt at a merger. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 30, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Groundbreaking National Study on PrEP Use to Prevent HIV Acquisition...
A groundbreaking national study from The Fenway Institute is the first to investigate PrEP use and the risk behaviors that indicate its use to prevent HIV among transgender MSM. Findings indicate that...(PRWeb September 30, 2019)Read the full story at https://www.prweb.com/releases/groundbreaking_national_study_on_prep_use_to_prevent_hiv_acquisition_among_transgender_msm/prweb16611850.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 30, 2019 Category: Pharmaceuticals Source Type: news

Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Acquisition is expected to realize over $10M in annual synergies Results in Currax owning the global rights to CONTRAVE® In connection with this transaction, Currax repaid 25% of its outstanding debt Currax anticipates revenues in excess of $1... Biopharmaceuticals, Mergers & Acquisitions Currax Pharmaceuticals, Nalpropion Pharmaceuticals, CONTRAVE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2019 Category: Pharmaceuticals Source Type: news

FDA approves BWXT's radiopharmaceutical
U.S. government nuclear components supplier BWX Technologies (BWXT) has received...Read more on AuntMinnie.comRelated Reading: BWXT completes acquisition of Nordion business BWXT selects Mo-99 irradiation provider Sotera Health to sell Nordion business (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2019 Category: Radiology Source Type: news

WellCare to divest health plans before Centene merger
A unit of WellCare Health Plans Inc. has agreed to sell its Missouri and Nebraska Medicaid plans to Anthem Inc. The deal is being made in connection with WellCare's pending acquisition by Centene Corp., the companies said Thursday. Terms of the deal weren't disclosed. The closing of the transaction with Indianapolis-based Anthem (NYSE: ANTM) is subject to federal antitrust clearance, state regulatory approvals and the closing of the Centene-WellCare deal, officials said. Anthem, a for-profit managed… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 26, 2019 Category: Biotechnology Authors: Diana Barr Source Type: news

Anthem To Buy Divested Centene-WellCare Medicaid Plans In Two States
Anthem will buy Medicaid operations owned by WellCare Health Plans in Missouri and Nebraska as part of a divestiture needed by Centene to win approval of its WellCare acquisition. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 26, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Juul boss exits in vaping crisis as Philip Morris, Altria axe merger talks
The chief executive of e-cigarette maker Juul stepped down on Wednesday as merger talks between its biggest investor Altria and Philip Morris collapsed in the face of a regulatory backlash against vaping that could reshape the industry. (Source: Reuters: Health)
Source: Reuters: Health - September 26, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Juul Shake-Up: C.E.O. Steps Down
In addition, the tobacco giant Altria, which has a stake in Juul, and Philip Morris International, said they were ending merger talks. (Source: NYT)
Source: NYT - September 25, 2019 Category: American Health Authors: Sheila Kaplan, Michael J. de la Merced and Julie Creswell Tags: E-Cigarettes Juul Labs Inc Smoking and Tobacco Respiratory Diseases Appointments and Executive Changes Recalls and Bans of Products Regulation and Deregulation of Industry Altria Group Inc Food and Drug Administration Philip Morris Compa Source Type: news

Juul CEO Steps Down, Vaping Company Suspends All U.S. Advertising Amid Backlash
(Bloomberg) — Juul Labs Inc. said Chief Executive Officer Kevin Burns will step down, as the highly valued private e-cigarette company confronts a growing public backlash. The company said in a statement that K.C. Crosthwaite will be joining the company as CEO effective immediately. Crosthwaite previously served as chief growth officer at Marlboro maker Altria Group Inc., which took a $13 billion stake in Juul last year. At the same time on Wednesday, Altria said it was ending merger talks with fellow tobacco giant Philip Morris International Inc. The companies said in a statement that they would focus on another smo...
Source: TIME: Health - September 25, 2019 Category: Consumer Health News Authors: Timothy Annett / Bloomberg Tags: Uncategorized health juul onetime Source Type: news

Rockville biotech looks for lifeline following restructuring
Rexahn Pharmaceuticals Inc. is standing at a crossroads. The Rockville biotech announced Tuesday an intention to consider “strategic alternatives” as it cuts staff and searches for ways to extend resources.  Potential moves include a merger or acquisition, reverse merger or other business combination. It could also mean licensing or selling off it s assets. CEO Doug Swirsky declined to comment beyond the company’s press release. Rexahn (NASDAQ: REXN) is also eliminating two positions and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2019 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Rockville biotech looks for lifeline following restructuring
Rexahn Pharmaceuticals Inc. is standing at a crossroads. The Rockville biotech announced Tuesday an intention to consider “strategic alternatives” as it cuts staff and searches for ways to extend resources.  Potential moves include a merger or acquisition, reverse merger or other business combination. It could also mean licensing or selling off it s assets. CEO Doug Swirsky declined to comment beyond the company’s press release. Rexahn (NASDAQ: REXN) is also eliminating two positions and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2019 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Apollo Hospitals eyes smaller acquisitions of up to Rs 300 crore
The company also hinted at going slow on investments from here, saying extracting benefits from past bets will be the focus now through margin expansion. (Source: The Economic Times)
Source: The Economic Times - September 25, 2019 Category: Consumer Health News Source Type: news

Sacramento mental health practice grows with SoCal acquisitions
Sacramento-based mental health practice Community Psychiatry Management LLC has added six more outpatient offices in Southern California through two acquisitions. Community Psychiatry Management bought Calabasas Behavioral Health of Calabasas and Gelbart and Associates of Torrance. The two acquisitions, completed in August, add new therapies and new employees to Community Psychiatry Management. In professional staff, the mergers add eight psychiatrists, 1 8 therapists and six psychologists to the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2019 Category: Pharmaceuticals Authors: Mark Anderson Source Type: news

How Can Medtech Help Deliver the Data and Value Healthcare Needs?
The medical technology industry broke records last year, “surpassing for the first time over $400 billion in revenue,” Jim Welch, global medtech leader for EY, told attendees at The Medtech Conference on September 24. Medtech "achieved over 7% in growth, which is fantastic and is actually a record since the economic crisis of 2008.” He cited figures on U.S. and European-based medical device companies as reported in EY’s 2019 medtech report, “Pulse of the Industry: As Data Personalizes Medtech, How Will You Serve Tomorrowâ&#...
Source: MDDI - September 24, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news

Heal expands to New York with Doctors on Call acquisition
Heal Inc., the Los Angeles health-tech startup that specializes in doctor house calls, has acquired Doctors on Call, which offers medical house call services to the elderly in New York. The move enables Heal's entry into its largest single city and makes its services available to more than 75 million people throughout California, Atlanta, Washington, D.C.; northern Virginia and now New York. Doctors on Call averaged 42,000 house calls to seniors in New York City last year. Term s of the deal were… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 23, 2019 Category: Pharmaceuticals Authors: Annlee Ellingson Source Type: news

Heal expands to New York with Doctors on Call acquisition
Heal Inc., the Los Angeles health-tech startup that specializes in doctor house calls, has acquired Doctors on Call, which offers medical house call services to the elderly in New York. The move enables Heal's entry into its largest single city and makes its services available to more than 75 million people throughout California, Atlanta, Washington, D.C.; northern Virginia and now New York. Doctors on Call averaged 42,000 house calls to seniors in New York City last year. Term s of the deal were… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2019 Category: Biotechnology Authors: Annlee Ellingson Source Type: news

Heal's house call platform pushes into New York with latest acquisition
Doctors on Call, a house call service proving care over the last 50 years for senior patients, will be joining the app-driven startup. (Source: mobihealthnews)
Source: mobihealthnews - September 23, 2019 Category: Information Technology Source Type: news

Adherence to HIV post-exposure prophylaxis for children/adolescents who have been sexually assaulted: A systematic review of barriers, enablers, and interventions - Shubber Z, Ford N.
Post-exposure prophylaxis (PEP) is a key intervention for preventing HIV acquisition, including following sexual assault. However, uptake and completion rates for HIV PEP are lowest following sexual assault, with only 40% reporting completing the 28-day co... (Source: SafetyLit)
Source: SafetyLit - September 21, 2019 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

FitBit considering sale to investment bank: Report
San Francisco-based wearable device maker Fitbit Inc has been communicating with an investment bank regarding a sale, Reuters reported Friday. Qatalyst has been seeking to persuade Fitbit to consider sale options for several weeks, arguing it could attract acquisition interest from Google owner Alphabet Inc. (NASDAQ: GOOG), Reuters reported, but FitBit (NYSE: FIT) has not yet decided on its course of action. Reuters based the story on "p eople familiar with the matter," as the sources asked not to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2019 Category: Biotechnology Authors: SFBT Staff Report Source Type: news

FitBit considering sale to investment bank: Report
San Francisco-based wearable device maker Fitbit Inc has been communicating with an investment bank regarding a sale, Reuters reported Friday. Qatalyst has been seeking to persuade Fitbit to consider sale options for several weeks, arguing it could attract acquisition interest from Google owner Alphabet Inc. (NASDAQ: GOOG), Reuters reported, but FitBit (NYSE: FIT) has not yet decided on its course of action. Reuters based the story on "p eople familiar with the matter," as the sources asked not to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2019 Category: Pharmaceuticals Authors: SFBT Staff Report Source Type: news

S.F.'s FitBit considering sale to investment bank: Report
San Francisco-based wearable device maker Fitbit Inc has been communicating with an investment bank regarding a sale, Reuters reported Friday. Qatalyst has been seeking to persuade Fitbit to consider sale options for several weeks, arguing it could attract acquisition interest from Google owner Alphabet Inc. (NASDAQ: GOOG), Reuters reported, but FitBit (NYSE: FIT) has not yet decided on its course of action. Reuters based the story on "p eople familiar with the matter," as the sources asked not to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2019 Category: Biotechnology Authors: SFBT Staff Report Source Type: news

S.F.'s FitBit considering sale to investment bank: Report
San Francisco-based wearable device maker Fitbit Inc has been communicating with an investment bank regarding a sale, Reuters reported Friday. Qatalyst has been seeking to persuade Fitbit to consider sale options for several weeks, arguing it could attract acquisition interest from Google owner Alphabet Inc. (NASDAQ: GOOG), Reuters reported, but FitBit (NYSE: FIT) has not yet decided on its course of action. Reuters based the story on "p eople familiar with the matter," as the sources asked not to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2019 Category: Pharmaceuticals Authors: SFBT Staff Report Source Type: news